Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00554)
| DIG Name |
Sodium ascorbate
|
||||
|---|---|---|---|---|---|
| Synonyms |
SODIUM ASCORBATE; L-Ascorbic acid sodium salt; 134-03-2; Sodium L-ascorbate; Vitamin C sodium; Ascorbic acid sodium salt; Monosodium L-ascorbate; Ascorbicin; Sodascorbate; Natrii ascorbas; Vitamin C, sodium salt; ascorbate; Ascorbate de sodium; L-Ascorbic acid, monosodium salt; Ascorbin; MFCD00082340; UNII-S033EH8359; L(+)-Ascorbic acid sodium salt; Vitamin C Sodium Salt; (+)-Sodium L-ascorbate; Sodium (R)-2-((S)-1,2-dihydroxyethyl)-4-hydroxy-5-oxo-2,5-dihydrofuran-3-olate; S033EH8359; Cebitate; Aminofenitrooxon; sodium (2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-olate; Iskia-C; Natri-C; sodium (L)-ascorbate; sodiumascorbate; C6H7NaO6; Ascorbato sodico; Ascorbato sodico [DCIT]; sodium;(2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-olate; Natrii ascorbas [INN-Latin]; Ascorbic acid sodium derivative; CCRIS 3291; HSDB 694; 3-Oxo-L-gulofuranolactone sodium; HBL 508; L-Ascorbic acid sodium; Ascorbate de sodium [INN-French]; EINECS 205-126-1; Tianafacacid; Sodium ascorbate [USP:INN]; L-Ascorbic acid, sodium salt (1:1); Sodium derivative of 3-oxo-L-gulofuranolactone; ascorbic acid sodium; E301; sodium L-ascorbate salt; DSSTox_CID_105; 58657-35-5; EC 205-126-1; SCHEMBL3745; DSSTox_RID_75369; DSSTox_GSID_20105; L(+)Ascorbic acid sodium salt; CHEMBL591665; INS NO.301; DTXSID0020105; HY-B0166A; INS-301; CHEBI:113451; L-Ascorbic Acid Sodium Salt,(S); L-Ascorbic Acid - Monosodium Salt; Tox21_300556; AKOS015895058; CS-6063; DB14482; sodium (2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2,5-dihydrofuran-3-olate; NCGC00254355-01; BP-30077; CAS-134-03-2; M609; A0539; B1834; E-301; A806721; Q424551; J-006471; sodium (2R)-2-[(1S)-1,2-bis(oxidanyl)ethyl]-4-oxidanyl-5-oxidanylidene-2H-furan-3-olate
|
||||
| DIG Function |
Antioxidant
|
||||
| Formula |
C6H7NaO6
|
||||
| Canonical SMILES |
C([C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O)O.[Na+]
|
||||
| InChI |
1S/C6H8O6.Na/c7-1-2(8)5-3(9)4(10)6(11)12-5;/h2,5,7-10H,1H2;/q;+1/p-1/t2-,5+;/m0./s1
|
||||
| InChIKey |
PPASLZSBLFJQEF-RXSVEWSESA-M
|
||||
| Physicochemical Properties | Molecular Weight | 198.11 | Topological Polar Surface Area | 110 | |
| XlogP | N.A. | Complexity | 237 | ||
| Heavy Atom Count | 13 | Rotatable Bond Count | 2 | ||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | ||
Full List of Drug(s) Co-administrated with This DIG